4.3 Article

Over 90% of cases of Microscopic Colitis can be diagnosed by performing a short colonoscopy

Journal

Publisher

ELSEVIER MASSON
DOI: 10.1016/j.clinre.2016.12.008

Keywords

-

Ask authors/readers for more resources

Aims: To determinate the topographical distribution of key diagnostic histological features of lymphocytic colitis (LC) and collagenous colitis (CC) and to establish what correlations may exist between the histological findings and the causes and severity of MC. Patients and methods: Patients with MC were included in a prospective multicentre French study from September 2010 to October 2012. MC was diagnosed by performing total colonoscopy with multiple biopsies of the rectum and colon collected in separate jars and analyzed separately for each site (descending and sigmoid colon, transverse colon, ascending colon). CC was defined as a subepithelial collagen layer > 10 mu m thick and LC as an intraepithelial lymphocyte(IEL) count > 20 lymphocytes per 100 epithelial cells without any associated thickening of the subepithelial collagen. Results: Ninety-five patients, 69 with LC 26 and with CC, were included in the analysis. The sensitivity of the biopsies for diagnosing MC was maximum in the transverse colon and minimumin the rectum. Rectal and left colonic biopsies resulted in the diagnosis of CC and CL in 93% and 94% of cases, respectively. All the remaining cases of MC were diagnosed by performing additional biopsies beyond the splenic flexure. In patients with LC, a higher rate of IELs was associated with the absence of abdominal pain (P = 0.01) and a shorter duration of diarrhea( P = 0.001). In patients with CC, a lower level of collagen thickness in the basement membrane was associated with the presence of an autoimmune disease (P = 0.02). Conclusion: More than 90% of cases of microscopic colitis were diagnosed in this study by performing rectal and left colonic biopsies. (C) 2017 Elsevier Masson SAS. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Letter Gastroenterology & Hepatology

Reducing the Need for Random Colonic Biopsies in Patients With Diarrhea Response

Gilles Macaigne, Pierre Lahmek, Stephane Nahon, Alexandre Pariente

AMERICAN JOURNAL OF GASTROENTEROLOGY (2015)

Article Gastroenterology & Hepatology

The effects of aminosalicylates or thiopurines on the risk of colorectal cancer in inflammatory bowel disease

F. Carrat, P. Seksik, J. -F. Colombel, L. Peyrin-Biroulet, L. Beaugerie

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2017)

Article Gastroenterology & Hepatology

Effectiveness and Safety of Vedolizumab Induction Therapy for Patients With Inflammatory Bowel Disease

Aurelien Amiot, Jean-Charles Grimaud, Laurent Peyrin-Biroulet, Jerome Filippi, Benjamin Pariente, Xavier Roblin, Anthony Buisson, Carmen Stefanescu, Caroline Trang-Poisson, Romain Altwegg, Philippe Marteau, Thibaud Vaysse, Anne Bourrier, Stephane Nancey, David Laharie, Matthieu Allez, Guillaume Savoye, Jacques Moreau, Charlotte Gagniere, Lucine Vuitton, Stephanie Viennot, Alexandre Aubourg, Anne-Laure Pelletier, Guillaume Bouguen, Vered Abitbol, Yoram Bouhnik

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2016)

Article Gastroenterology & Hepatology

Diagnostic Delay Is Associated with a Greater Risk of Early Surgery in a French Cohort of Crohn's Disease Patients

Stephane Nahon, Pierre Lahmek, Thierry Paupard, Bruno Lesgourgues, Stanislas Chaussade, Laurent Peyrin-Biroulet, Vered Abitbol

DIGESTIVE DISEASES AND SCIENCES (2016)

Article Gastroenterology & Hepatology

Rate and Predictors of Mucosal Healing in Ulcerative Colitis Treated with Thiopurines: Results of a Multicentric Cohort Study

Caroline Prieux-Klotz, Stephane Nahon, Aurelien Amiot, Leila Sinayoko, Carole Galeano-Cassaz, Stanislas Chaussade, Romain Coriat, Pierre Lahmek, Vered Abitbol

DIGESTIVE DISEASES AND SCIENCES (2017)

Article Gastroenterology & Hepatology

Negative Screening Does Not Rule Out the Risk of Tuberculosis in Patients with Inflammatory Bowel Disease Undergoing Anti-TNF Treatment: A Descriptive Study on the GETAID Cohort

Yael Abitbol, David Laharie, Jacques Cosnes, Matthieu Allez, Stephane Nancey, Aurelien Amiot, Alexandre Aubourg, Mathurin Fumery, Romain Altwegg, Pierre Michetti, Elise Chanteloup, Philippe Seksik, Clotilde Baudry, Mathurin Flamant, Guillaume Bouguen, Carmen Stefanescu, Anne Bourrier, Gilles Bommelaer, Nina Dib, Marc Andre Bigard, Stephanie Viennot, Xavier Hebuterne, Jean-Marc Gornet, Philippe Marteau, Yoram Bouhnik, Vered Abitbol, Stephane Nahon

JOURNAL OF CROHNS & COLITIS (2016)

Article Gastroenterology & Hepatology

Middle-term mortality and re-bleeding after initial diverticular bleeding: A nationwide study of 365 mostly elderly French patients

Diane Lorenzo, Claire Gallois, Pierre Lahmek, Bruno Lesgourgues, Christine Champion, Claire Charpignon, Roger Faroux, Bruno Bour, Andre-Jean Remy, Chantal Naouri, Magali Picon, Eric Poncin, Gilles Macaigne, Jacques-Arnaud Seyrig, David Bernardini, Guy Bellaiche, Denis Grasset, Jean Henrion, Frederic Heluwaert, Rene Piperaud, Gilbert Bordes, Francois Bourhis, Jean-Pierre Arpurt, Alexandre Pariente, Stephane Nahon

UNITED EUROPEAN GASTROENTEROLOGY JOURNAL (2017)

Article Gastroenterology & Hepatology

Long-term outcome of patients with steroid-refractory acute severe UC treated with ciclosporin or infliximab

D. Laharie, A. Bourreille, J. Branche, M. Allez, Y. Bouhnik, J. Filippi, F. Zerbib, G. Savoye, L. Vuitton, J. Moreau, A. Amiot, J. Cosnes, E. Ricart, O. Dewit, A. Lopez-Sanroman, M. Fumery, F. Carbonnel, G. Bommelaer, B. Coffin, X. Roblin, G. van Assche, M. Esteve, M. Farkkila, J. P. Gisbert, P. Marteau, S. Nahon, M. de Vos, J. Lambert, J. Y. Mary, E. Louis

Article Gastroenterology & Hepatology

Microscopic Colitis or Functional Bowel Disease With Diarrhea: A French Prospective Multicenter Study

Gilles Macaigne, Pierre Lahmek, Christophe Locher, Bruno Lesgourgues, Laurent Costes, Max Pierre Nicolas, Anne Courillon-Mallet, Jean-Michel Ghilain, Guy Bellaiche, Stephanie de Montigny-Lehnardt, Georges Barjonet, Rene-Louis Vitte, Roger Faroux, Benedicte Lambare, Antoine Fleury, Alexandre Pariente, Stephane Nahon

AMERICAN JOURNAL OF GASTROENTEROLOGY (2014)

Article Gastroenterology & Hepatology

Impact of complementary and alternative medicine on the quality of life in inflammatory bowel disease: results from a French national survey

Vered Abitbol, Pierre Lahmek, Anne Buisson, Alain Olympie, Cecile Poupardin, Stanislas Chaussade, Bruno Lesgourgues, Stephane Nahon

EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2014)

Article Medicine, General & Internal

Measuring patients' satisfaction with their anti-TNF treatment in severe Crohn's disease: scoring and psychometric validation of the Satisfaction for PAtients in Crohn's diseasE Questionnaire (SPACE-Q©)

Helene Gilet, Benoit Arnould, Fatoumata Fofana, Pierre Clerson, Jean-Frederic Colombel, Olivier D'Hondt, Patrick Faure, Herve Hagege, Maria Nachury, Stephane Nahon, Gilbert Tucat, Luc Vandromme, Ines Cazala-Telinge, Emmanuel Thibout

PATIENT PREFERENCE AND ADHERENCE (2014)

Article Gastroenterology & Hepatology

Diagnostic impact of routine colonoscopy following acute diverticulitis: A multicenter study in 808 patients and controls

Stephane Lecleire, Stephane Nahon, Abdullah Alatawi, Michel Antonietti, Ulriikka Chaput, Aude Di-Fiore, Raied Alhameedi, Philippe Marteau, Philippe Ducrotte, Xavier Dray

UNITED EUROPEAN GASTROENTEROLOGY JOURNAL (2014)

Article Medicine, General & Internal

Orientation of Adult Patients consulting in the Emergencies for Digestive Bleeding (Without Proved or Presumed Portal Hypertension): Interest of the Prognostic Scores

E. Zamparini, P. Ahmed, M. Belhassan, C. Horaist, A. Bouguerba, S. Ayed, J. Barchasz, M. Boukari, D. Goldgran-Toledano, S. Yaacoubi, C. Bornstain, S. Nahon, F. Vincent

REANIMATION (2017)

Article Gastroenterology & Hepatology

One-year effectiveness and safety of vedolizumab therapy for inflammatory bowel disease: a prospective multicentre cohort study

A. Amiot, M. Serrero, L. Peyrin-Biroulet, J. Filippi, B. Pariente, X. Roblin, A. Buisson, C. Stefanescu, C. Trang-Poisson, R. Altwegg, P. Marteau, T. Vaysse, A. Bourrier, S. Nancey, D. Laharie, M. Allez, G. Savoye, J. Moreau, L. Vuitton, S. Viennot, A. Aubourg, A. -L. Pelletier, G. Bouguen, V. Abitbol, C. Gagniere, Y. Bouhnik

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2017)

Review Gastroenterology & Hepatology

New developments and standard of care in the management of advanced gastric cancer

Leonard Depotte, Juliette Palle, Cosimo Rasola, Chloe Broudin, Vlad-Adrian Afrasanie, Antoine Mariani, Aziz Zaanan

Summary: Advanced gastric adenocarcinoma is a disease with poor prognosis. In recent years, new drugs, such as trastuzumab for HER2-positive tumors, ramucirumab alone or in combination with paclitaxel, and trifluridine-tipiracil, have improved patient survival. Other drugs, including monoclonal antibodies and targeted therapies, are also being evaluated.

CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY (2024)